Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
Big Data and the Needs of the Pharma Industry, a Thomson Reuters whitepaper surveying IT leaders within pharma, found that access to external content is the industry’s top challenge around managing the ever-growing Big Data environment. Cortellis Data Fusion provides users with seamless access to internal and external content and the ability to aggregate, integrate and analyze large volumes of varied data through a single, user-friendly interface.
“Cortellis Data Fusion gives us the ability to tie together information about entities like diseases and genes and the connections between them. We can do this from Cortellis data, from third party data, from a client's internal data or from all of these at the same time. Our analytics enable the client to then explore these connections and identify unexpected associations, leading to new discoveries",” said Chris Bouton, general manager, Thomson Reuters Life Sciences. “Driving novel insights for our clients is at the very core of our mission and these technologies help to enable that.”
The faster and deeper insight from Cortellis Data Fusion is possible because content is parsed into manageable, actionable Little Data. There are inherent, intuitive data analytic links that enable users to discover unexpected associations, generate hypotheses and share novel ideas. The solution also employs enterprise information security architecture ensuring proprietary data and analyses remain safe.
Opportunities created by Cortellis Data Fusion are a result of the recent acquisition by Thomson Reuters of Entagen, an industry-leader in providing semantic search/navigation software and custom development services to large pharma, biotech and laboratory automation companies.
Learn more about Cortellis Data Fusion.